Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results

@article{Morimoto2013SalvageHI,
  title={Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results},
  author={Masahiro Morimoto and Fumiaki Isohashi and Yasuo Yoshioka and Osamu Suzuki and Yuji Seo and Toshiyuki Ogata and Yuichi Akino and Masahiko Koizumi and Kazuhiko Ogawa},
  journal={International Journal of Clinical Oncology},
  year={2013},
  volume={19},
  pages={312-318}
}
We retrospectively examined outcomes of salvage high-dose-rate interstitial brachytherapy (HDR-ISBT) for locally recurrent rectal cancer (LRRC). Nine patients with LRRC were treated with salvage HDR-ISBT. Their median age was 63 years. The median maximum diameter of LRRC was 40 mm (range 20–80 mm). Adenocarcinomas were histologically confirmed in all cases… CONTINUE READING